89. Lymphangioleiomyomatosis
38 clinical trials,   42 drugs   (DrugBank: 19 drugs),   26 drug target genes,   134 drug target pathways

Searched query = "Lymphangioleiomyomatosis", "LAM"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04388371
(ClinicalTrials.gov)
October 18, 201911/5/2020Glutamine PET Imaging in LAMGlutamine PET Imaging in LAMLymphangioleiomyomatosis (LAM)Drug: GlutamineVanderbilt University Medical CenterThe LAM FoundationEnrolling by invitation18 YearsN/AFemale5Phase 1United States